Related references
Note: Only part of the references are listed.Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
Berengere Villeret et al.
FRONTIERS IN IMMUNOLOGY (2020)
A case report of community-acquired Pseudomonas aeruginosa pneumonia complicated with MODS in a previously healthy patient and related literature review
Tao Wang et al.
BMC INFECTIOUS DISEASES (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study
M. Coppry et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Increased incidence of co-infection in critically ill patients with influenza
Ignacio Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2017)
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa
Catia Cilloniz et al.
CHEST (2016)
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Youn Jeong Kim et al.
BMC INFECTIOUS DISEASES (2014)
Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children:: analysis of forty-three episodes
YC Huang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Share Paper
